Navigation Links
Galderma announces approval for Differin gel 0.1 percent in Japan
Date:7/17/2008

Lausanne, Switzerland July 16, 2008 Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, announced today that Japan's Ministry of Health, Labor and Welfare has approved Differin® Gel 0.1% (adapalene), a novel topical treatment for acne vulgaris in Japan. The drug will be marketed in Japan by Galderma KK, the fully-owned Japanese arm of Galderma, and strategic alliance partner Shionogi.

Differin® has been available for over 15 years and is currently marketed in more than 80 countries, where it has become an important therapy for more than 22 million patients. Approval in Japan will reinforce Galderma's presence in the world's second-largest pharmaceutical market. Approval was based on non-clinical and clinical studies, which supported the efficacy and safety of the product for the registration outside Japan and on an extensive local clinical development program, including two phase 3 studies enrolling more than 600 Japanese patients.

A 12-week study of the treatment in 200 Japanese patients demonstrated that treatment with Differin® Gel 0.1% led to a significant reduction in both inflammatory and non-inflammatory lesions, as compared with vehicle treatment, with some patients feeling the benefit after only one week of treatment. A 12-month long-term safety study of more than 400 patients showed that the treatment was safe and remained effective with long-term use.

"The collective results of three recent adapalene studies provide a substantial evidence base for the safe and effective use of adapalene gel 0.1% in Japanese patients with acne," said Clinical Trial Lead Investigator Makoto Kawashima, MD, PhD Department of Dermatology Tokyo Women's Medical University. "The availability of a topical retinoid in Japan will provide greater flexibility for customizing care and improving outcomes for acne patients."

According to the agreement between both firms, Galderma and Shionogi w
'/>"/>

Contact: Dale Weiss
dale.weiss@galderma.com
817-961-5186
WeissComm Partners
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Galderma Completes Tender Offer for CollaGenex
2. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
3. ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
4. Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
5. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
6. Galderma Associates Itself to Cartiers Womens Initiative Awards to Recognize Female Entrepreneurs From Around the Globe
7. Fresh Harvest Products, Inc. Announces New Brand Initiative
8. AMN Healthcare Announces Joint Commission Re-Certification
9. Peptimmune Announces the Second Close of Series D Private Financing
10. Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah
11. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Encino, CA (PRWEB) June 18, 2013 ... road to recovery from autism. He receives 40 hours ... services and school shadowing) from the Center for Autism ... with CARD since August, 2008, and has experienced remarkable ... and commenting about his environment. Riley’s personal journey through ...
(Date:6/18/2013)... cells have a much different and more complex ... University of Texas at Dallas have found that exploiting ... lung cancer. , In an article published online May ... Dallas researchers compared the metabolic characteristics of non-small-cell lung ... same patient. , They found that the cancer ...
(Date:6/18/2013)... CLEVELANDA new commercial venture, using technology developed at ... Sciences and Case School of Engineering, has made ... SimuCase allows graduate students and others training to ... Web-based program, reducing stress on the trainee, because ... a real person. , Graduate students studying ...
(Date:6/18/2013)... 2013 More than 1.1 million people in ... according to the Centers for Disease Control and Prevention (CDC). ... In support of National HIV Testing Day on June 27, ... (SSDI) representation, the CDC and other organizations are raising ... CDC reports about 50,000 new HIV infections each year. Along ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The Elizabeth ... of State and the U.S. President’s Emergency Plan for ... and celebrate significant new milestones in the global effort ... John Kerry announced that as of June 2013, one ... PEPFAR support. Since PEPFAR’s inception in 2003, EGPAF ...
Breaking Medicine News(10 mins):Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:SimuCase avatars advance speech-language pathology training 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3
... study has broken the hopes that a combination of ... alternative for preventing strokes //in people with the abnormal ... therapy, of warfarin. ,Canadian researchers have cut ... there is a higher incidence of not only of ...
... Haryana Health Minister Kartar Devi today said government had increased ... education by 50 per cent this fiscal to implement various ... a five-day yoga training camp, being conducted by Swami Ramdev ... necessary to popularise yoga in view of our rich cultural ...
... progressive degeneration of the nerves across the body. Some ... and Kennedy disease. // Researchers have found that ... of the transport of proteins within cells. Hence they ... is unraveled then these diseases could be easily treated. ...
... A 26-year-old woman has delivered identical quadruplets, a rarity ... globally, at a corporate hospital here. // ... girl babies- Aditi, Aakriti, Akshathi, Aapthi, at the Apollo ... her full term, without any medical complications, doctors said., ...
... Pharma major Ranbaxy Laboratories Ltd has entered into a ... Zonisamide Capsules // , which are used for the ... the agreement products would be developed and submitted for ... the products under the the company's label. , ...
... detected here today even as health officials collected blood ... the disease. // ,Officials said a team ... including two children were suffering from jaundice., ,The ... the area as doctors collected blood samples of 20 ...
Cached Medicine News:Health News:Studies Show Combination Drugs As A Poor Substitute For Anti-Coagulants In Stroke 2Health News:Transport of Proteins Unravels the Mystery behind Neurodegenerative Diseases 2
(Date:6/17/2013)... , June 17, 2013 Velplex, LLC announced ... a technology platform that connects buyers and sellers of ... an industry leader. Why? It,s because ... are intimately familiar with the dental industry. They have ... and have diligently worked to negotiate some of the ...
(Date:6/17/2013)... DNAtrix Inc., experts in oncolytic virus development, ... on the company,s lead product, DNX-2401, at the Replicating ... Canada on June 18, 2013. ... leader in the field of oncolytic virus therapy, will ... I TRIAL OF A CONDITIONALLY REPLICATION-COMPETENT ADENOVIRUS DNX-2401 (FORMERLY ...
(Date:6/17/2013)... ST. PAUL, Minn. , June 17, 2013 ... and branding and design agency, Larsen, was awarded the Silver ... Purpose, Repositioning Prime Therapeutics." The award was presented at the ... Awards Ceremony held June 13 at the AXA ... The Silver Anvil, which has been presented ...
Breaking Medicine Technology:TopProdeals.com Rises to Top as Discount Dental Supply Leader 2DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus 2Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2
... March 23 Magellan Biosciences, Inc., an emerging ... has become the first to offer minocycline and telavancin ... and Drug Administration (FDA) has cleared TREK-brand Sensititre MIC ... negative bacterial isolates, as well as telavancin against Gram ...
... and MORRISTOWN, N.J. , March 23 MicroMass Communications, Inc., a world leader in behavioral marketing, ... be supporting the launch of the new center and its mission of promoting the growth of North Carolina ,s ... ... , , ...
Cached Medicine Technology:FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre(R) In Vitro Diagnostic (IVD) MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared for Streptococcus Pneumoni 2FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre(R) In Vitro Diagnostic (IVD) MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared for Streptococcus Pneumoni 3FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre(R) In Vitro Diagnostic (IVD) MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared for Streptococcus Pneumoni 4MicroMass Named Agency of Record for North Carolina Advanced Medical Technologies Center of Innovation 2MicroMass Named Agency of Record for North Carolina Advanced Medical Technologies Center of Innovation 3MicroMass Named Agency of Record for North Carolina Advanced Medical Technologies Center of Innovation 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: